ACADIAN ASSET MANAGEMENT LLC - TCR2 THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,217
+39.6%
812,459
-7.1%
0.01%
+25.0%
Q4 2022$872
-99.9%
874,853
+28.1%
0.00%
-42.9%
Q3 2022$1,228,000
-21.8%
683,114
+26.1%
0.01%
-12.5%
Q2 2022$1,571,000
+18.8%
541,875
+13.0%
0.01%
+60.0%
Q1 2022$1,322,000
+1933.8%
479,518
+3250.7%
0.01%
Q4 2021$65,000
+364.3%
14,311
+710.4%
0.00%
Q1 2020$14,0001,7660.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$62,221,00018.51%
MPM BioImpact LLC 3,370,982$51,778,00013.77%
Redmile Group, LLC 1,765,188$27,113,0000.50%
ArrowMark Colorado Holdings LLC 1,356,010$20,828,0000.22%
DAFNA Capital Management LLC 46,183$709,0000.20%
Artal Group S.A. 350,000$5,376,0000.15%
WFA of San Diego, LLC 4,733$540,0000.13%
Granite Point Capital Management, L.P. 100,000$1,536,0000.08%
HHLR ADVISORS, LTD. 322,903$4,960,0000.04%
SPHERA FUNDS MANAGEMENT LTD. 30,000$461,0000.04%
View complete list of TCR2 THERAPEUTICS INC shareholders